Cargando…

Pulmonary hypertension in chronic lung diseases: comparison to other pulmonary hypertension groups

Group 3 pulmonary hypertension (PH) is a common complication of advanced chronic lung disease. Our hypothesis was that group 3 PH is associated with a more severe baseline presentation and a more severe prognosis compared to group 1 pulmonary arterial hypertension (PAH), chronic thromboembolic PH (g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chebib, Nader, Mornex, Jean-François, Traclet, Julie, Philit, François, Khouatra, Chahera, Zeghmar, Sabrina, Turquier, Ségolène, Cottin, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012471/ https://www.ncbi.nlm.nih.gov/pubmed/29671674 http://dx.doi.org/10.1177/2045894018775056

Ejemplares similares

Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertension
por: Ginoux, Marylise, et al.
Publicado: (2018)

Safety of right heart catheterization for pulmonary hypertension in very elderly patients
por: Ginoux, Marylise, et al.
Publicado: (2018)

Pulmonary hypertension in hereditary haemorrhagic telangiectasia is associated with multiple clinical conditions
por: Margelidon-Cozzolino, Victor, et al.
Publicado: (2021)

Right-to-left shunt with hypoxemia in pulmonary hypertension
por: Vodoz, Jean-Frédéric, et al.
Publicado: (2009)

Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem
por: Chebib, Nader, et al.
Publicado: (2017)

Lung Dual-Energy CT Perfusion Blood Volume as a Marker of Severity in Chronic Thromboembolic Pulmonary Hypertension
por: Si-Mohamed, Salim A., et al.
Publicado: (2023)

In vivo demonstration of pulmonary microvascular involvement in COVID-19 using dual-energy computed tomography
por: Si-Mohamed, Salim, et al.
Publicado: (2020)

Sustained response to low-dose nifedipine in a patient with idiopathic pulmonary arterial hypertension
por: Nasser, Mouhamad, et al.
Publicado: (2018)

Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis
por: Grobost, Vincent, et al.
Publicado: (2014)

Nintedanib in idiopathic and secondary pleuroparenchymal fibroelastosis
por: Nasser, Mouhamad, et al.
Publicado: (2021)

Improvement with Infliximab of a Disseminated Sarcoidosis in a Patient with Crohn's Disease
por: Chebib, Nader, et al.
Publicado: (2014)

Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension
por: Mismetti, Valentine, et al.
Publicado: (2023)

Effect of cladribine therapy on lung cysts in pulmonary Langerhans cell histiocytosis
por: Nasser, Mouhamad, et al.
Publicado: (2018)

Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody
por: Gossez, Morgane, et al.
Publicado: (2015)

Clinical case: Combined pulmonary fibrosis and emphysema with pulmonary hypertension – clinical management
por: Cottin, Vincent
Publicado: (2013)

Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability
por: Revuz, Sabine, et al.
Publicado: (2017)

Updates in pulmonary hypertension and other pulmonary vascular diseases
por: Bernardo, Roberto J., et al.
Publicado: (2019)

Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2020)

Beyond the Diagnosis of Group IV Pulmonary Hypertension: Chronic Thromboembolic Pulmonary Hypertension Mimickers
por: Chima, Noor Rehman, et al.
Publicado: (2020)

Role of micro-RNAs 21, 124 and other novel biomarkers in distinguishing between group 1 WHO pulmonary hypertension and group 2, 3 WHO pulmonary hypertension
por: Dimitry, Mark O., et al.
Publicado: (2023)

Combined Modalities Treatment of Pulmonary Metastasis from an Urachal Adenocarcinoma
por: Piégay, Fabrice, et al.
Publicado: (2013)

Tacrolimus-Related Cerebral Microbleeds after Lung Transplantation
por: Mechtouff, L., et al.
Publicado: (2013)

Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literature
por: Sanges, Sébastien, et al.
Publicado: (2016)

Assessment of Daily Life Physical Activities in Pulmonary Arterial Hypertension
por: Mainguy, Vincent, et al.
Publicado: (2011)

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis
por: Launay, David, et al.
Publicado: (2018)

Group 3 pulmonary hypertension: Challenges and opportunities
por: McGettrick, Michael, et al.
Publicado: (2020)

The Biological Bases of Group 2 Pulmonary Hypertension
por: Fernández, Ana I., et al.
Publicado: (2019)

COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study
por: Montani, David, et al.
Publicado: (2022)

Pulmonary paracoccidioidomycosis‐induced pulmonary hypertension
por: Batah, Sabrina Setembre, et al.
Publicado: (2020)

Pulmonary hypertension with dasatinib and other tyrosine kinase inhibitors
por: El-Dabh, Ashraf, et al.
Publicado: (2019)

Exercise-Induced Changes in Pulmonary Artery Stiffness in Pulmonary Hypertension
por: Forouzan, Omid, et al.
Publicado: (2019)

Pulmonary Hypertension
por: Basyigit, Ilknur, et al.
Publicado: (2012)

Pulmonary hypertension
por: Vonk Noordegraaf, Anton, et al.
Publicado: (2016)

Pulmonary venous remodeling in COPD-pulmonary hypertension and idiopathic pulmonary arterial hypertension
por: Andersen, Kasper Hasseriis, et al.
Publicado: (2017)

Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension
por: Hautefort, Aurélie, et al.
Publicado: (2017)

Alternatives to the Six-Minute Walk Test in Pulmonary Arterial Hypertension
por: Mainguy, Vincent, et al.
Publicado: (2014)

Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update
por: Vonk Noordegraaf, Anton, et al.
Publicado: (2019)

Signal transduction in the development of pulmonary arterial hypertension
por: Malenfant, Simon, et al.
Publicado: (2013)

Characteristics and survival data from Latvian pulmonary hypertension registry: comparison of prospective pulmonary hypertension registries in Europe
por: Skride, Andris, et al.
Publicado: (2018)

An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants
por: Montani, David, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h7tnk3k61guvpih02is3au8jeq